Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Sleep Apnea's Double Impact On Stroke

Date: Oct-02-2012
In order to prevent stroke, there needs to be significant improvements in the diagnosis and screening of sleep apnea, suggests new guidelines on stroke care released today at the Canadian Stroke Congress. Obstructive sleep apnea is the most common type of sleep apnea, where the flow of air pauses or decreases during sleep because the airway has narrowed or blocked. It is a disorder that not only increases the chance of having a stroke, but it can also be a serious complication after the person suffers a strokeb, the Canadian Best Practice Recommendations for Stroke Care indicates...

Unacceptably High Failure Rates Found In Hip Resurfacing Operations

Date: Oct-02-2012
Hip resurfacing, often used as an alternative to hip replacements for young patients, has been revealed to fail early and most often in women. A new study published in The Lancet, examined data from 434,650 hip operations done between April 2003 and September 2011, of which 7.3 percent were resurfacings. The study viewed the amount of resurfacing implants that failed in the initial seven years after surgery and whether the head size of the implant played a role in the failure...

Genetically Modified Cow Produces Low Allergy Milk

Date: Oct-02-2012
Scientists have genetically modified a cow which now produces high casein protein milk that is low in beta-lactoglobulin (BLG), a milk whey protein some babies are allergic to, says a report published in the Proceedings of the National Academy of Sciences (PNAS). Scientists from AGResearch and the University of Waikato, New Zealand, say this is a world first; a GM (genetically modified) cow which can produce milk which is much less likely to cause allergic reactions...

Smoking Leads To Poor Memory In Stroke Patients

Date: Oct-02-2012
Smokers have a harder time solving problems and making decisions after having a stroke than non-smokers, according to a study which was presented at the Canadian Stroke Congress. Using the Montreal Cognitive Assessment (MoCA) tool, the researchers examined the mental capabilities of 76 patients with the average age of 67.5 - 12 of them were smokers. The MoCA is a test in which patients answer questions regarding memory and problem solving and receive a score out of 30. The test was given to patients from stroke facilities in Hamilton, Barrie and Oshawa...

Sitting For Long Periods Increases Risk Of Kidney Disease

Date: Oct-02-2012
Individuals who sit for several hours of the day not only put themselves at risk for obesity and sore limbs, but also increase their chances of developing kidney disease...

People Worldwide Living Longer, A New Challenge, Says United Nations

Date: Oct-02-2012
Longer lifespans are not only occurring in developed nations. By 2050, four-fifths of the world's elderly people will be in developing nations, and there will be more seniors aged 60+ than children aged 15 or less, UN Secretary-General, Ban Ki-moon said today to mark the International Day of Older Persons. A new report, issued by the United Nations (UN) urges governments across the world to address the needs of elderly people, who are currently the fastest growing segment of global populations. Seniors require policies aimed at them, as well as laws and strategies for their own protection...

News From The Journal Of Clinical Investigation: October 1, 2012

Date: Oct-02-2012
Sphingolipid metabolism contributes to diabetes-associated heart disease Patients with type 2 diabetes are subject to a number of major health risks, including a greatly increased risk of heart failure. This is due in part to the development of diabetic cardiomyopathy (DbCM), a condition that significantly impairs heart function...

Northwest Bio Proceeding With A Phase I/Ii Clinical Trial Of Dcvax®-Direct For All Solid Tumor Cancers

Date: Oct-02-2012
Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it is in late stage discussions with medical centers in the U.S. and Europe to proceed with a Phase I/II clinical trial with the Company's third major product line, DCVax®-Direct, for all types of solid tumor cancers (i.e., cancers in any tissues). The Company previously received FDA approval of the clinical trial...

Latest Developments In Techniques And Procedures Used In The Identification And Control Of Contaminants, 30-31 January 2013, London

Date: Oct-02-2012
Microbiological contamination of products and processes in a lab and manufacturing environment continues to be a major problem to the Pharmaceutical and Biotechnological industries and its regulators. The potential impact of such contamination can be enormous, and does not only create health and safety problems but can also cost companies millions in lost product revenue. Regulators will endeavour to ensure that the safety of the health care consumer is never compromised...

Free 2nd World Drug Discovery Online Conference, October 16-18, 2012

Date: Oct-02-2012
Target Meeting's 2nd World Drug Discovery Online Conference will be held on October 16 - 18, 2012. The 12 sessions, which will be spread over three days, will discuss Herbal drug development, General pharmaceutical research, Biotechnology and biopharmaceuticals, Drug delivery & targeting, Vaccine development, Preclinical development, Clinical trial, and many more...